102 related articles for article (PubMed ID: 3135996)
1. [The topography of P300 in neuropsychiatric pharmacotherapy. III. Cognitive P300 fields in an organic psychosyndrome (Wilson's disease) before and during treatment with D-penicillamine].
Maurer K; Ihl R; Dierks T
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1988 Jun; 19(2):62-4. PubMed ID: 3135996
[TBL] [Abstract][Full Text] [Related]
2. [Electrophysiological changes of the brain in Wilson's disease under D-penicillamine treatment].
Fujita T; Fujita H; Okawa M; Yokoi S
Rinsho Shinkeigaku; 1976 May; 16(5):381-8. PubMed ID: 986276
[No Abstract] [Full Text] [Related]
3. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
Germinario L; Campanella G; D'Addabbo A
Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
[No Abstract] [Full Text] [Related]
4. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
[TBL] [Abstract][Full Text] [Related]
5. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
6. [EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
Lang HD; Reichenmiller HE; Tigges FJ; Braun HJ; Golisch G
Med Klin; 1972 Jun; 67(26):916-21. PubMed ID: 5048687
[No Abstract] [Full Text] [Related]
7. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
9. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
10. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
11. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
12. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Lange J; Brandt G
Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
[No Abstract] [Full Text] [Related]
13. [Treatment of Wilson's disease with zinc. 5 cases].
Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
[TBL] [Abstract][Full Text] [Related]
14. [On the therapeutic combination of S-adenosylmethionine with D-penicillamine in Wilson's disease].
Gasbarrini G; Miglio F; Corazza GR; Stefanini GF
Minerva Med; 1975 May; 66(33):1600-4. PubMed ID: 1143693
[TBL] [Abstract][Full Text] [Related]
15. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
Hansen J; Andersen OS
Ugeskr Laeger; 1969 Jul; 131(31):1306-9. PubMed ID: 5824791
[No Abstract] [Full Text] [Related]
16. [Topography of P300 in psychiatry--II. Cognitive P300 fields in dementia].
Maurer K; Ihl R; Dierks T
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1988 Mar; 19(1):26-9. PubMed ID: 3131106
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
18. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
19. Results of treatment of Wilson's disease--own observations.
Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
[TBL] [Abstract][Full Text] [Related]
20. [Wilson's disease (hepatolenticular degeneration)].
Bickel H
Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
[No Abstract] [Full Text] [Related]
[Next] [New Search]
